• Intranasal and Inhaled Corticosteroids and the COVID-19 Pandemic

    ACAAI Statement on Intranasal and Inhaled Corticosteroids and the COVID-19 Pandemic As spring allergy season sets in, allergy and asthma sufferers may be concerned that continuing their normal use of inhaled and intranasal corticosteroids may not be advisable during the pandemic. However, it is more important than ever for these patients to keep their symptoms

    Read more →
  • FDA Alerts Patients of EpiPen auto-injector errors

    FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration   Today the US Food and Drug Administration (FDA) is alerting patients, caregivers and health care professionals that EpiPen 0.3 mg and EpiPen Jr 0.15 mg auto-injectors, and the authorized generic versions, may potentially have delayed injection

    Read more →
  • Attention Patients: COVID-19

    Attention Patients! With the many unknowns due to the outbreak of the Coronavirus, the physicians of Midwest Allergy and Asthma Clinic would like to encourage our patients to consider not only receiving care in the clinic, but over the phone as well. The Coronavirus is a respiratory disease and as an allergy and asthma clinic

    Read more →
  • Important Update: COVID-19

    An important message to our Midwest Allergy and Asthma patients: Your health and safety are of the utmost importance to us. As we face the global spread of the Coronavirus (COVID-19), we want you to know we’ve implemented screening protocols for patients and staff and we’re doing everything possible to assure a clean, disinfected clinic.

    Read more →